COLDSTREAM CAPITAL MANAGEMENT INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1082339 BELLEVUE, WA

Position in HALO

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$572,815

-$24,203 QoQ

Shares Held

8,863

-0.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 60.75820828162022.ToString("F0")% Shared 0.ToString("F0")% None 39.24179171837978.ToString("F0")%

Healthcare · as of Mar 31, 2026

COLDSTREAM CAPITAL MANAGEMENT INC holds $11,059,687 across 19 Biotechnology names. HALO ranks #5 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,537	$2,919,031
2	REGN	Regeneron Pharmaceuticals, Inc.	1,874	$1,447,927
3	JAZZ	Jazz Pharmaceuticals plc	3,404	$643,526
4	INSM	INSMED Inc	3,737	$611,074
5	HALO	Halozyme Therapeutics, Inc. This page	8,863	$572,815
6	OMER	Omeros Corp	54,130	$571,612
7	MRNA	Moderna, Inc.	8,859	$450,037
8	ALNY	Alnylam Pharmaceuticals, Inc.	1,351	$447,005

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$572,815	8,863	-0.1%	Shares	Sole	2026-05-08
2025-12-31	$597,018	8,871	-0.5%	Shares	Sole	2026-02-09
2025-09-30	$653,752	8,914	+1.9%	Shares	Sole	2025-11-19
2025-06-30	$455,122	8,749	-4.6%	Shares	Sole	2025-08-12
2025-03-31	$585,392	9,174	+1.3%	Shares	Sole	2025-05-13
2024-12-31	$432,823	9,053	-2.1%	Shares	Sole	2025-02-14
2024-09-30	$529,527	9,251	+34.7%	Shares	Sole	2024-11-18
2024-06-30	$359,556	6,867	+1.8%	Shares	Sole	2024-08-07
2024-03-31	$274,305	6,743	-2.6%	Shares	Sole	2024-05-14
2023-12-31	$255,800	6,921	+40.4%	Shares	Sole	2024-02-09
2022-12-31	$280,517	4,930	+8.1%	Shares	Sole	2023-01-10
2022-06-30	$200,728	4,562	—	Shares	Sole	2022-08-08
No filing history on record for this holder in this stock.